Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
BCMA as a Target in Heavily Pretreated Multiple Myeloma
CME/CE education from PER®
Lively expert panel discussions featuring peer-to-peer exchanges
Overview of FLT3-Mutated AML
OncClub: Join the Chat on Trending Trials in Cancer
BCMA as a Target in Heavily Pretreated Multiple Myeloma
CME/CE education from PER®
Lively expert panel discussions featuring peer-to-peer exchanges
Overview of FLT3-Mutated AML
Specialty
View More
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
Podcasts Series
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
Podcasts Series
State of the Science Summit / IPC
Webinars
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Community
Interactive Tools
Learning Modules
Partners
Sponsored
Community
Interactive Tools
Learning Modules
Partners
Sponsored
Subscribe
eNewsletter
eNewsletter
Search
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
BCMA as a Target in Heavily Pretreated Multiple Myeloma
CME/CE education from PER®
Lively expert panel discussions featuring peer-to-peer exchanges
Overview of FLT3-Mutated AML
Specialty
See All >
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
January 21, 2016 - Episode 1
Delayed Decision on CINV Therapy, Priority Review in RCC, and CSS Highlights
January 21, 2016
Now Viewing
EP. 1: Delayed Decision on CINV Therapy, Priority Review in RCC, and CSS Highlights
Related Content:
January 21, 2016
Genitourinary Cancers
Supportive Care
Dr. Dreicer on the Clinical Implications of the JAVELIN Bladder 100 Trial in Urothelial Cancer
Pal Provides Perspective on Pivotal Trials in RCC and Prostate Cancer
Intermediate/Poor-Risk mRCC: Treatment Selection
